Why Are Anti-Parasitic drugs effective against The COV-2 Virus And Why Is The CDC Denying This?, Save Colorado

Why Are Anti-Parasitic drugs effective against The COV-2 Virus And Why Is The CDC Denying This?

Numerous studies have been done at this point showing that Hydroxychloroquine and Ivermectin, both well known anti-parasitics, are extremely effective in stopping COVID-19 infections. Despite their “stop the spread of COVID at all costs” mantra, the CDC doesn’t really seem to want it to stop. If they did, why are they so adamantly against their use in the treatment of CoV-2 infections?

A June update from the CDC reads as follows:

June 15, 2020 Update: Based on ongoing analysis and emerging scientific data, FDA has revoked the emergency use authorization (EUA) to use hydroxychloroquine and chloroquine to treat COVID-19 in certain hospitalized patients when a clinical trial is unavailable or participation is not feasible. We made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery. This outcome was consistent with other new data, including those showing the suggested dosing for these medicines are unlikely to kill or inhibit the virus that causes COVID-19. As a result, we determined that the legal criteria for the EUA are no longer met. Please refer to the Revocation of the EUA Letter and FAQs on the Revocation of the EUA for Hydroxychloroquine Sulfate and Chloroquine Phosphate for more information.

A follow up came just 2 weeks later:

July 1, 2020 Update: A summary of the FDA review of safety issues with the use of hydroxychloroquine and chloroquine to treat hospitalized patients with COVID-19 is now available. This includes reports of serious heart rhythm problems and other safety issues, including blood and lymph system disorders, kidney injuries, and liver problems and failure.

The following is from Lab experiments show anti-parasitic drug, Ivermectin, eliminates SARS-CoV-2 in cells in 48 hours [news release]. Monash University; April 3, 2020. https://www.monash.edu/discovery-institute/news-and-events/news/2020-articles/Lab-experiments-show-anti-parasitic-drug,-Ivermectin,-eliminates-SARS-CoV-2-in-cells-in-48-hours.

“A study led by researchers at Monash University has found that the widely available anti-parasitic drug ivermectin is capable of killing the coronavirus disease 2019 (COVID-19) within 48 hours in a cell culture. Although the finding is promising, the researchers cautioned that the tests conducted were in vitro and that trials need to be carried out in humans.

“Ivermectin is very widely used and seen as a safe drug,” said Kylie Wagstaff, PhD, leader of the study, in a statement. “We need to figure out now whether the dosage you can use it at in humans will be effective—that’s the next step.” Ivermectin is an FDA-approved anti-parasitic drug, which has also shown efficacy in vitro against viruses such as HIV, and the Dengue, influenza, and Zika viruses. “We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it,” Wagstaff said.”

In as far as hydroxychloroquine goes, the following information came from Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows https://www.henryford.com/news/2020/07/hydro-treatment-study

In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19.

“The findings have been highly analyzed and peer-reviewed,” said Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, who co-authored the study with Henry Ford epidemiologist Samia Arshad. “We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring. Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.”

So what is the link between anti-parasitic drugs and CoV-2? Why do drugs not intended for the treatment of viral ailments seem to work? And if they do work well in treating COVID-19, which they seem to do, why would the CDC go on a rampage against their use? They are not new, they are well established and were safe enough at the time to get the FDA seal of approval. It seems to me that the CDC read the warnings and precautions and used them to be a justification to admonish their use in the treatment of COVID.

The entire world has seemingly beaten this thing with a few exceptions solely in the West. If one didn’t know better, one might think that the powers that be are dragging this on intentionally, inflating the numbers, lying about statistics, and squashing known remedies. We do know better…right?

#COVID19 #CDC #COLORADO #DENVER #PANDEMIC #JAREDPOLIS Why Are Anti-Parasitic drugs effective against The COV-2 Virus And Why Is The CDC Denying This?, Save Colorado